Search

Biosynthesis of β-carotene in engineered E. coli using the MEP and MVA pathways

메타 데이터

바이오화학분류
    • 화장품용 기능성소재
      1. 기능성
      2. 계면활성제⁄증점제
    • 의료용 화학소재
      1. 건강보조식품
논문

Biosynthesis of β-carotene in engineered E. coli using the MEP and MVA pathways

학술지

Microbial cell factories

저자명

Yang, Jianming; Guo, Lizhong

초록

<P><B>Background</B></P><P>&beta;-carotene is a carotenoid compound that has been widely used not only in the industrial production of pharmaceuticals but also as nutraceuticals, animal feed additives, functional cosmetics, and food colorants. Currently, more than 90% of commercial &beta;-carotene is produced by chemical synthesis. Due to the growing public concern over food safety, the use of chemically synthesized &beta;-carotene as food additives or functional cosmetic agents has been severely controlled in recent years. This has reignited the enthusiasm for seeking natural &beta;-carotene in large-scale fermentative production by microorganisms.</P><P><B>Results</B></P><P>To increase &beta;-carotene production by improving the isopentenyl pyrophosphate (IPP) and geranyl diphospate (GPP) concentration in the cell, the optimized MEP (methylerythritol 4-phosphate) pathway containing 1-deoxy-D-xylulose-5-phosphate synthase (DXS) and isopentenyl pyrophosphate isomerase (FNI) from <I>Bacillus subtilis</I>, geranyl diphosphate synthase (GPPS2) from <I>Abies grandis</I> have been co-expressed in an engineered <I>E. coli</I> strain. To further enhance the production of &beta;-carotene, the hybrid MVA (mevalonate) pathway has been introduced into an engineered <I>E. coli</I> strain, co-expressed with the optimized MEP pathway and GPPS2. The final genetically modified strain, YJM49, can accumulate 122.4±6.2&nbsp;mg/L &beta;-carotene in flask culture, approximately 113-fold and 1.7 times greater than strain YJM39, which carries the native MEP pathway, and YJM45, which harbors the MVA pathway and the native MEP pathway, respectively. Subsequently, the fermentation process was optimized to enhance &beta;-carotene production with a maximum titer of 256.8±10.4&nbsp;mg/L. Finally, the fed-batch fermentation of &beta;-carotene was evaluated using the optimized culture conditions. After induction for 56&nbsp;h, the final engineered strain YJM49 accumulated 3.2&nbsp;g/L &beta;-carotene with a volumetric productivity of 0.37&nbsp;mg/(L · h · OD<SUB>600</SUB>) in aerobic fed-batch fermentation, and the conversion efficiency of glycerol to &beta;-carotene (gram to gram) reached 2.76%.</P><P><B>Conclusions</B></P><P>In this paper, by using metabolic engineering techniques, the more efficient biosynthetic pathway of &beta;-carotene was successfully assembled in <I>E. coli</I> BL21(DE3) with the optimized MEP (methylerythritol 4-phosphate) pathway, the gene for GPPS2 from <I>Abies grandis</I>, the hybrid MVA (mevalonate) pathway and &beta;-carotene synthesis genes from <I>Erwinia herbicola</I>.</P><P><B>Electronic supplementary material</B></P><P>The online version of this article (doi:10.1186/s12934-014-0160-x) contains supplementary material, which is available to authorized users.</P>

발행연도

2014

발행기관

BioMed Central

라이선스

cc-by

ISSN

1475-2859

13

페이지

pp.160

주제어

β-carotene; MEP pathway; MVA pathway; E. coli

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

1건의 후보군 물질이 있습니다.

1 2023-12-11

논문; 2014-11-18

Export

About

Search

Trend